Live Newswire19 stories on the wire
The Wire
Every headline that moves the tape, paired with the why, in plain English.
AllBreakingMarketsEconomyFederal ReserveEarningsCompanyAnalyst ActionsTechnologyEnergyCryptocurrency
Lead StoryEarnings05:51 PM ET
XCHG Sees FY2026 Sales $32.900M-$38.200M
XCHG (NASDAQ:XCH) sees FY2026 sales of $32.900 million-$38.200 million.
Why it
matters
matters
XCHG told investors it expects to earn between $32.9 million and $38.2 million next year. When a company gives you a range like this, watch if they hit it later on.
AI-Generated · Educational · Not Advice
Read full story →Source · Benzinga
In this story
ReadNeutral
Latest18 stories
05:35 PM ETEarnings
SB
Marygold Companies Q4 EPS $(0.08) Down From $(0.04) YoY, Sales $6.925M Down From $7.200M YoY
WhyMarygold lost more money per share than it did last year. The company also made less total money, so watch if it can turn things around soon.
MGLDSource · Benzinga
05:26 PM ETEarnings
SB
Neuphoria Therapeutics Q4 EPS $(0.95) Misses $(0.56) Estimate, Sales $1.174M.
WhyNeuphoria lost more money per share than expected this quarter. When a company loses more than people thought, watch if they explain why clearly.
NEUPSource · Benzinga
04:17 PM ETEarnings
SB
UPDATE: XCharge H1 Adj. EPS $(0.003) Vs. $(0.002) YoY, Sales $10.271M Vs. $12.451M YoY
WhyXCharge made a tiny loss per share this year, slightly worse than last year. Sales dropped from 12 million to 10 million dollars, showing the business is shrinking.
XCHSource · Benzinga
04:07 PM ETEarnings
SB
Lobo EV Technologies H1 EPS $(0.07) Up From $(0.28) YoY, Sales $14.587M Up From $12.091M YoY
WhyLobo EV is losing less money than it did last year. Sales are growing, which shows the company is moving in a better direction.
LOBOSource · Benzinga
12:37 PM ETEarnings

AutoNation Stock Slides as Softer Q3 Outlook Raises Margin Concerns
WhyAutoNation said its profits might be smaller soon. Watch if car sellers can still make money when times get tougher.
ANXMVMBTALSource · Benzinga
09:58 AM ETEarnings
SB
Reported earlier, Steel Dynamics Sees Q3 GAAP EPS $5.34-$5.38 vs $5.66 Est
WhySteel Dynamics says its third quarter earnings will be lower than experts predicted. When a company misses what people expected, it can mean business was tougher than planned.
STLDSource · Benzinga
09:57 AM ETEarnings
SB
Reported earlier, Nucor Sees Q3 GAAP EPS $5.55-$5.65 vs $6.17 Est
WhyNucor says it will earn less money than experts thought in Q3. When a company earns less than people expected, that shows business might be weaker than hoped.
NUESource · Benzinga
09:13 AM ETEarnings

Transcript: Caledonia Mining Q2 2026 Earnings Conference Call
WhyCaledonia Mining shared its spring profits and answered investor questions. Listen for clues about gold production and future cash flow plans.
CMCLSource · Benzinga
08:28 AM ETEarnings

Freightos Q2 2026 Earnings Call: Complete Transcript
WhyFreightos shared how it did in the last three months. Listen to what leaders said about the shipping business to understand what comes next.
CRGOSource · Benzinga
08:23 AM ETEarnings
SB
Progressive Reports August EPS $1.63, Down 21% YoY, And Net Premiums Earned $951M, Down 22% YoY
WhyProgressive made less money per share this year than last year. When a company earns less, watch whether customers are leaving or if costs went up.
PGRSource · Benzinga
08:10 AM ETEarnings

B2Gold Q2 2026 Earnings Call: Complete Transcript
WhyB2Gold shared how its gold business performed in the second quarter. Listen for what leaders say about gold prices and future mining plans.
TSX:BTOSource · Benzinga
08:04 AM ETEarnings
SB
Chanson International H1 EPS $0.64 Up From $(286.93) YoY, Sales $8.296M Down From $8.688M YoY
WhyChanson went from losing lots of money to making a tiny profit. This big swing happened even though sales got a little smaller.
CHSNSource · Benzinga
08:02 AM ETEarnings
SB
Corcept Therapeutics Says CHMP Recommends EU Approval Of Relacorilant With Nab-Paclitaxel For Platinum-Resistant Ovarian Cancer; EC Decision Expected In Q4 2026
WhyA European committee said yes to a new cancer medicine from Corcept. The final approval decision should happen later in 2026.
CORTSource · Benzinga
07:50 AM ETEarnings

Transcript: East Side Games Group Q2 2026 Earnings Conference Call
WhyEast Side Games shared their spring money results with investors on a call. Listen for what the company said about growth, profits, and their plans ahead.
TSX:EAGRSource · Benzinga
07:31 AM ETEarnings
SB
Beneficient Plans To Launch Alternative Asset Portfolio Analytics And Risk Platform AltLens In Q4 Of Calendar Year 2026
WhyBeneficient is building a new tool to help people understand alternative investments. When it launches next year, watch if it helps the company attract more clients and grow.
BENFSource · Benzinga
07:08 AM ETEarnings
SB
BlossomHill Therapeutics Q2 EPS $(8.75)
WhyBlossomHill lost more money per share this quarter than last year. When a company's losses grow bigger, it means they are spending cash faster than before.
BLSMSource · Benzinga
07:05 AM ETEarnings
SB
Cato Corporation To Close ~70 Additional Underperforming Stores In Q3 And Q4; Brings FY26 Total Planned Stores Closures To ~120; Sees $1M-$1.3M In Associated Costs
WhyCato is closing about 70 more stores that aren't making money. When a company closes stores, it shows the business is struggling to find places customers want to shop.
CATOMMMSource · Benzinga
06:55 AM ETEarnings

Transcript: Zoom Communications Q2 2027 Earnings Conference Call
WhyZoom shared its earnings results and answered questions from investors. When a company talks openly about numbers, you can listen for clues about growth and plans ahead.
ZMSource · Benzinga
Educational commentary, not financial advice. No outcomes guaranteed. Headlines link to the original publisher.